892 related articles for article (PubMed ID: 33164664)
21. Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2.
Mishra SK; Priya P; Rai GP; Haque R; Shanker A
Comput Biol Med; 2023 Sep; 163():107233. PubMed ID: 37422941
[TBL] [Abstract][Full Text] [Related]
22. A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.
Kibria KMK; Faruque MO; Islam MSB; Ullah H; Mahmud S; Miah M; Saleh AA
Appl Microbiol Biotechnol; 2022 Jun; 106(11):4091-4114. PubMed ID: 35612630
[TBL] [Abstract][Full Text] [Related]
23. Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins.
Rajput VS; Sharma R; Kumari A; Vyas N; Prajapati V; Grover A
J Biomol Struct Dyn; 2022; 40(19):9096-9113. PubMed ID: 34038700
[TBL] [Abstract][Full Text] [Related]
24. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
Jain N; Shankar U; Majee P; Kumar A
Infect Genet Evol; 2021 Jan; 87():104648. PubMed ID: 33264668
[TBL] [Abstract][Full Text] [Related]
25. A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein.
Martin WR; Cheng F
J Biomol Struct Dyn; 2022 Sep; 40(15):7099-7113. PubMed ID: 33715598
[TBL] [Abstract][Full Text] [Related]
26. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M
Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041
[TBL] [Abstract][Full Text] [Related]
27. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
Dong R; Chu Z; Yu F; Zha Y
Front Immunol; 2020; 11():1784. PubMed ID: 32849643
[TBL] [Abstract][Full Text] [Related]
28. A candidate multi-epitope vaccine against SARS-CoV-2.
Kar T; Narsaria U; Basak S; Deb D; Castiglione F; Mueller DM; Srivastava AP
Sci Rep; 2020 Jul; 10(1):10895. PubMed ID: 32616763
[TBL] [Abstract][Full Text] [Related]
29.
Bayani F; Safaei Hashkavaei N; Karamian MR; Uskoković V; Sefidbakht Y
J Biomol Struct Dyn; 2023; 41(21):11748-11762. PubMed ID: 36703619
[TBL] [Abstract][Full Text] [Related]
30. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
[TBL] [Abstract][Full Text] [Related]
31. An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest.
Saba AA; Adiba M; Saha P; Hosen MI; Chakraborty S; Nabi AHMN
Comput Biol Med; 2021 Sep; 136():104703. PubMed ID: 34352457
[TBL] [Abstract][Full Text] [Related]
32. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
33. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
Singh J; Malik D; Raina A
Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
[TBL] [Abstract][Full Text] [Related]
34. Exploring the S Protein of SARS-CoV-2 to Design a Novel Multi-Epitope Vaccine against COVID-19 Based on Immunoinformatics Approaches.
Huang Z; Shi H; Gong H; Sun Q; Yang S; Zhang Y; Shi Z; Xia Z; Huang S; Yao S; Xu F
Front Biosci (Landmark Ed); 2024 May; 29(5):196. PubMed ID: 38812300
[TBL] [Abstract][Full Text] [Related]
35. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
[TBL] [Abstract][Full Text] [Related]
36. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide.
Srivastava S; Verma S; Kamthania M; Agarwal D; Saxena AK; Kolbe M; Singh S; Kotnis A; Rathi B; Nayar SA; Shin HJ; Vashisht K; Pandey KC
J Biomol Struct Dyn; 2022 Mar; 40(5):2369-2388. PubMed ID: 33155524
[TBL] [Abstract][Full Text] [Related]
37. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
[TBL] [Abstract][Full Text] [Related]
38. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Akhtar N; Joshi A; Singh B; Kaushik V
Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
[TBL] [Abstract][Full Text] [Related]
39. Immunoinformatics prediction of overlapping CD8
Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
[TBL] [Abstract][Full Text] [Related]
40. Designing of Nucleocapsid Protein Based Novel Multi-epitope Vaccine Against SARS-COV-2 Using Immunoinformatics Approach.
Kumar J; Qureshi R; Sagurthi SR; Qureshi IA
Int J Pept Res Ther; 2021; 27(2):941-956. PubMed ID: 33192207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]